Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway
Makoto Kunisaki(Joslin Diabetes Center), George L. King(Joslin Diabetes Center), Lawrence M. Ballas(SPX Corporation (United States)), Sven–Erik Bursell(Joslin Diabetes Center), Allen C. Clermont(Joslin Diabetes Center), M.R. Jirousek(Eli Lilly (United States)), F. Umeda(Joslin Diabetes Center), H Nawata(Joslin Diabetes Center), Hideki Ishii(Gunma University)
American Journal of Physiology-Endocrinology and Metabolism
August 1, 1995
Cited by 157
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
|Circulation Research|2010|979